INO
Price:
$6.28
Market Cap:
$163.06M
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, pen...[Read more]
Industry
Biotechnology
IPO Date
1998-12-08
Stock Exchange
NASDAQ
Ticker
INO
According to Inovio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.24. This represents a change of -23.57% compared to the average of -1.62 of the last 4 quarters.
The mean historical PE Ratio of Inovio Pharmaceuticals, Inc. over the last ten years is -55.77. The current -1.24 PE Ratio has changed 122.36% with respect to the historical average. Over the past ten years (40 quarters), INO's PE Ratio was at its highest in in the September 2020 quarter at 300.16. The PE Ratio was at its lowest in in the June 2015 quarter at -265.07.
Average
-55.77
Median
-26.05
Minimum
-188.42
Maximum
-1.00
Discovering the peaks and valleys of Inovio Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 136.20%
Maximum Annual PE Ratio = -1.00
Minimum Annual Increase = -94.09%
Minimum Annual PE Ratio = -188.42
Year | PE Ratio | Change |
---|---|---|
2023 | -1.00 | -22.39% |
2022 | -1.29 | -62.08% |
2021 | -3.41 | -46.54% |
2020 | -6.38 | 136.20% |
2019 | -2.70 | -94.09% |
2018 | -45.71 | -0.51% |
2017 | -45.95 | -44.28% |
2016 | -82.46 | -56.24% |
2015 | -188.42 | 4.49% |
2014 | -180.32 | 85.59% |
The current PE Ratio of Inovio Pharmaceuticals, Inc. (INO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.90
5-year avg
-2.96
10-year avg
-55.77
Inovio Pharmaceuticals, Inc.’s PE Ratio is less than Novavax, Inc. (0), greater than Vaxart, Inc. (-5.86), greater than Enveric Biosciences, Inc. (-2.16), less than CohBar, Inc. (-0.36), less than Ocean Biomedical, Inc. (-0.20), less than Hepion Pharmaceuticals, Inc. (-0.17), less than Elevation Oncology, Inc. (-0.15), less than AVROBIO, Inc. (-0.93), less than null (2.07),
Company | PE Ratio | Market cap |
---|---|---|
0 | $1.86B | |
-5.86 | $201.33M | |
-2.16 | $4.53M | |
-0.36 | $1.25M | |
-0.20 | $33.96M | |
-0.17 | $4.20M | |
-0.15 | $36.94M | |
-0.93 | $5.24M | |
2.07 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inovio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Inovio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Inovio Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Inovio Pharmaceuticals, Inc. (INO)?
What is the highest PE Ratio for Inovio Pharmaceuticals, Inc. (INO)?
What is the 3-year average PE Ratio for Inovio Pharmaceuticals, Inc. (INO)?
What is the 5-year average PE Ratio for Inovio Pharmaceuticals, Inc. (INO)?
How does the current PE Ratio for Inovio Pharmaceuticals, Inc. (INO) compare to its historical average?